9 C
October 27, 2020

Romania, strategic market for Glenmark Pharmaceuticals Ltd

Romania ranks first in Central and Eastern Europe based on the company Glenmark Pharmaceuticals Ltd’s turnover trend, according to a press release remitted to “Nine O’Clock”. The other key-countries in the region in which the company operates are Poland, the Czech Republic and Slovakia. Glenmark Pharmaceuticals Romania has doubled its sales in the past two years, while relying exclusively on local funding. In under three years since its entry on the market (in 2008), Glenmark Pharmaceuticals has swept from the 99th to the 41st position on the pharmaceutical market and to 15th place on the generics market.

Related posts

Enel Romania has new CFO

Nine O' Clock

Hagag Development Europe completes the structure of the first three buildings in H Pipera Lake


Affan Yildirim, General Manager of Anchor Group in Romania: 2016 isn’t only a year in which we achieved success, but one in which Anchor Group made history once more in Romania

Leave a Comment